首页|我国药品集中采购利益相关主体行为策略研究——基于演化博弈视角

我国药品集中采购利益相关主体行为策略研究——基于演化博弈视角

扫码查看
目的 为我国药品集中带量采购的稳定运行提供参考.方法 基于演化博弈理论,构建集采政策利益相关主体的演化博弈模型,通过模型分析各方策略选择的演化稳定性,探究其影响因素及机理.结果 医保局对医疗机构和医生的奖惩是影响医疗机构考核和医生配合使用中选药品的主要因素;医保局补贴数额的增加,会影响其自身监督的概率;医疗机构考核成本的增加,使医疗机构考核、医保局监督的概率下降.结论 医保局的奖惩政策、医疗机构的考核评估以及医生的配合态度都对集采的稳定运作起到至关重要的作用.建议医保局奖惩并施,细化结余留用政策;医疗机构建立考核机制,进行差异化管理,同时增强成本控制意识;医生积极配合考核,辅助医疗机构成本控制,三方合作推动我国集采政策稳定运行.
Research on the behavioral strategies of stakeholder subjects in centralized procurement of drugs in China—based on the perspective of evolutionary game
Objective To provide a reference for the stable operation of the centralized procurement of drugs in China.Methods Based on the evolutionary game theory,the evolutionary game model of the main stakeholders in centralized drug procurement policy was constructed,the evolutionary stability of the strategic choices of all parties was analyzed through the model,and its influencing factors and mechanism were explored.Results The rewards and punishments of the National Healthcare Security Administration(NHSA)for medical institutions and doctors were the main factors affecting the assessment of medical institutions and the cooperation of doctors in using the selected drugs;the increase in subsidy amount of the NHSA affected the probability of its own supervision;the increase in assessment costs of medical institutions led to a decrease in the probability of the assessment of medical institutions and the supervision by the NHSA.Conclusion The reward and punishment policies of the NHSA,the assessment and evaluation of medical institutions,and the cooperative attitude of doctors all play a crucial role in the stable operation of the centralized procurement of drugs.It is suggested that the NHSA should apply both rewards and punishments and refine the balance retention policy;medical institutions should establish an assessment mechanism for differentiated management and enhance the awareness of cost control;doctors should actively cooperate with the assessment and assist in the cost control of medical institutions;and the three parties should cooperate to promote the stable operation of the centralized procurement of drugs in China.

centralized drug procurementevolutionary gameNational Healthcare Security Administrationmedical institutions

杨晴、蔡静、李智勇、曾贱吉

展开 >

广东药科大学医药商学院,广东广州 510006

药品集中采购 演化博弈 医保局 医疗机构

广东省哲学社会科学规划项目广东省教育科学规划课题

GD21CJY022023GXJK324

2024

广东药科大学学报
广东药学院

广东药科大学学报

CSTPCD
影响因子:0.698
ISSN:1006-8783
年,卷(期):2024.40(2)
  • 13